Quest Diagnostics Reports Third Quarter 2016 Financial Results

Go back to Quest Diagnostics Reports Third Quarter 2016 Financial Results

Quest Diagnostics (DGX) Tops Q3 EPS by 2c; Narrows FY16 Outlook

October 20, 2016 6:46 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $1.37, $0.02 better than the analyst estimate of $1.35. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.89 billion.

GUIDANCE:

Quest Diagnostics sees FY2016 EPS of $5.07-$5.12, versus prior guidance of... More